Analysed BEONE MEDICINES LTD-ADR (ONC:NASDAQ) News Sources
BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit
11-06-2026
yahoo.com
BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026
12-06-2026
yahoo.com
BeOne Medicines (ONC): Citizens Sees an Inflection Point in Its Cancer Pipeline
22-06-2026
yahoo.com
Here is Why BeOne (ONC) One of the Most Promising Long-Term Stocks to Buy According to Analysts
23-06-2026
yahoo.com
BeOne Medicines Announces Positive Phase 3 Results for BRUKINSA in Frontline Mantle Cell Lymphoma
30-06-2026
yahoo.com
Exchange-Traded Funds Mixed, Equity Futures Lower Pre-Bell Ahead of Key Economic Reports
30-06-2026
yahoo.com
Is BeOne Medicines AG (ONC) Stock Positioned for Growth After Encouraging ASCO Cancer Data?
30-06-2026
yahoo.com
What is the current price of BEONE MEDICINES LTD-ADR (ONC:NASDAQ)?
The current price of BEONE MEDICINES LTD-ADR (ONC:NASDAQ) is $330.46.
BEONE MEDICINES LTD-ADR (ONC:NASDAQ) absolute price change since previous trading day?
The absolute price change of BEONE MEDICINES LTD-ADR (ONC:NASDAQ) since the previous trading day is $4.56.
BEONE MEDICINES LTD-ADR (ONC:NASDAQ) percentage price change since previous trading day?
The percentage price change of BEONE MEDICINES LTD-ADR (ONC:NASDAQ) since the previous trading day is 1.3992%.
What is the most recent average sentiment score for BEONE MEDICINES LTD-ADR (ONC:NASDAQ)?
The most recent average sentiment score for BEONE MEDICINES LTD-ADR (ONC:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for BEONE MEDICINES LTD-ADR (ONC:NASDAQ)?
The most recent sentiment for BEONE MEDICINES LTD-ADR (ONC:NASDAQ) is .
SEC-8K** Filing Available For BEONE MEDICINES LTD-ADR (ONC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.